Alkermes Plc (ALKS)
38.10
+0.75
(+2.01%)
USD |
NASDAQ |
May 27, 16:00
38.10
0.00 (0.00%)
After-Hours: 17:33
Alkermes Shareholders Equity (Quarterly) : 1.752B for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Amarin Corp. Plc | 449.41M |
| Xenon Pharmaceuticals, Inc. | 1.338B |
| Tyra Biosciences, Inc. | 387.58M |
| Spyre Therapeutics, Inc. | 670.81M |
| Agios Pharmaceuticals, Inc. | 1.109B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 4.258B |
| Total Liabilities (Quarterly) | 2.507B |
| Debt to Equity Ratio | 0.903 |
| Current Ratio | 2.266 |
| Net Debt Paydown Yield | -5.12% |